This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.
CLSI M33-A:2004
Original price was: $122.49.$61.00Current price is: $61.00.
Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE
Clinical and Laboratory Standards Institute , 02/01/2004
Pages: 39
